Bufexamac (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bufexamac" in English language version.

refsWebsite

Global rank English rank

3,984^th place

2,622^nd place

2^nd place

2^nd place

4^th place

4^th place

1semanticscholar.org

11^th place

8^th place

low place

low place

1web.archive.org

1^st place

1^st place

68^th place

117^th place

akdae.de

"Bufexamac: Ein Ekzemtherapeutikum, das selbst häufig allergische Kontaktekzeme hervorruft". Deutsches Ärzteblatt (in German) (47). 2000.

doi.org

Bantscheff M, Hopf C, Savitski MM, Dittmann A, Grandi P, Michon AM, et al. (March 2011). "Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes". Nature Biotechnology. 29 (3): 255–265. doi:10.1038/nbt.1759. PMID 21258344. S2CID 205275159.

europa.eu

ema.europa.eu

"European Medicines Agency recommends revocation of marketing authorisations for bufexamac" (PDF). European Medicines Agency. 2010-04-22. Archived from the original (PDF) on 2010-05-31. Retrieved 2010-05-01.

nih.gov

pubmed.ncbi.nlm.nih.gov

Bantscheff M, Hopf C, Savitski MM, Dittmann A, Grandi P, Michon AM, et al. (March 2011). "Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes". Nature Biotechnology. 29 (3): 255–265. doi:10.1038/nbt.1759. PMID 21258344. S2CID 205275159.

semanticscholar.org

api.semanticscholar.org

Bantscheff M, Hopf C, Savitski MM, Dittmann A, Grandi P, Michon AM, et al. (March 2011). "Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes". Nature Biotechnology. 29 (3): 255–265. doi:10.1038/nbt.1759. PMID 21258344. S2CID 205275159.

tga.gov.au

"Bufexamac Safety advisory - risk of serious skin reactions". Therapeutic Goods Administration. 2020.

web.archive.org

"European Medicines Agency recommends revocation of marketing authorisations for bufexamac" (PDF). European Medicines Agency. 2010-04-22. Archived from the original (PDF) on 2010-05-31. Retrieved 2010-05-01.